The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme
Open accessAbstract
Bacteriophage lytic enzymes quickly destroy the cell wall of the host bacterium to release progeny phage. Because such lytic enzymes specifically kill the species in which they were produced, they may represent an effective way to control pathogenic bacteria without disturbing normal microflora. In this report, we studied a murein hydrolase from the streptococcal bacteriophage C 1 termed lysin. This enzyme is specific for groups A, C, and E streptococci, with little or no activity toward several oral streptococci or other commensal organisms tested. Using purified lysin in vitro, we show that 1,000 units (10 ng) of enzyme is sufficient to sterilize a culture of ≈10 7 group A streptococci within 5 seconds. When a single dose of lysin (250 units) is first added to the oral cavity of mice, followed by 10 7 live group A streptococci, it provides protection from colonization (28.5% infected,n= 21) compared with controls without lysin (70.5% infected,n= 17) (P< 0.03). Furthermore, when lysin (500 units) was given orally to 9 heavily colonized mice, no detectable streptococci were observed 2 h after lysin treatment. In all, these studies show that lysin represents a unique murein hydrolase that has a rapid lethal effect both in vitro and in vivo on group A streptococci, without affecting other indigenous microorganisms analyzed. This general approach may be used to either eliminate or reduce streptococci from the upper respiratory mucosal epithelium of either carriers or infected individuals, thus reducing associated disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nasal Carriage as a Source of Staphylococcus aureus Bacteremia
von Eiff, C., Becker, K., Machka, K., Stammer, H., & Peters, G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440102 · Cited by 1,984
Bacteriophage lysis: mechanism and regulation
Young, R. (1992) · Microbiological Reviews · doi:10.1128/mmbr.56.3.430-481.1992 · Cited by 773
Bessen, D., Jones, K. F., & Fischetti, V. A. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.269 · Cited by 233
Self-citationELECTRON MICROSCOPIC STUDIES ON STREPTOCOCCI
Swanson, J., Hsu, K. C., & Gotschlich, E. C. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.130.5.1063 · Cited by 229
Molecular evolution of lytic enzymes of Streptococcus pneumoniae and its bacteriophages.
García, E., García, J. L., García, P., Arrarás, A., Sánchez-Puelles, J. M., & López, R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.3.914 · Cited by 173
The Pneumococcal Cell Wall Degrading Enzymes: A Modular Design to Create New Lysins?
LÓPEZ, R., García, E., García, P., & García, J. L. (1997) · Microbial Drug Resistance · doi:10.1089/mdr.1997.3.199 · Cited by 142
Size variation of the M protein in group A streptococci.
Fischetti, V. A., Jones, K. F., & Scott, J. R. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.161.6.1384 · Cited by 136
Self-citationBessen, D. E., & Fischetti, V. A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.4.1251 · Cited by 125
Self-citationSTUDIES ON BACTERIOPHAGES OF HEMOLYTIC STREPTOCOCCI
Krause, R. M. (1957) · The Journal of Experimental Medicine · doi:10.1084/jem.106.3.365 · Cited by 117
York, M. K., Gibbs, L., Perdreau‐Remington, F., & Brooks, G. F. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1727-1731.1999 · Cited by 113
MACRIS, M. H., Hartman, N., MURRAY, B., Klein, R. F., Roberts, R. B., Kaplan, E. L., HORN, D., & Zabriskie, J. B. (1998) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199805000-00006 · Cited by 99
Patron, R. L., Climo, M. W., Goldstein, B. P., & Archer, G. L. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1754 · Cited by 97
Group A Beta-hemolytic Streptococcal Infections
Pichichero, M. E. (1998) · Pediatrics in Review · doi:10.1542/pir.19-9-291 · Cited by 93
National Ambulatory Medical Care Survey: 1995-96 summary.
Schappert, S. M., & Nelson, C. (1999) · PubMed · Cited by 88
The Active Agent in Nascent Phage Lysis of Streptococci
Maxted, W. R. (1957) · Journal of General Microbiology · doi:10.1099/00221287-16-3-584 · Cited by 84
Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies.
Schaffner, W., Melly, M. A., Hash, J. H., & Koenig, M. (1967) · PubMed Central · Cited by 57
Streptococcal Pharyngitis: The Carrier State, Definition, and Management
Tanz, R. R., & Shulman, S. T. (1998) · Pediatric Annals · doi:10.3928/0090-4481-19980501-07 · Cited by 20
Cited by
Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences
Li, W., & Godzik, A. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl158 · Cited by 11,410
Roy, R., Tiwari, M., Donelli, G., & Tiwari, V. (2018) · Virulence · doi:10.1080/21505594.2017.1313372 · Cited by 1,523
Bacteriophage Endolysins as Novel Antimicrobials
Schmelcher, M., Donovan, D. M., & Loessner, M. J. (2012) · Future Microbiology · doi:10.2217/fmb.12.97 · Cited by 785
A bacteriolytic agent that detects and kills Bacillus anthracis
Schuch, R., Nelson, D., & Fischetti, V. A. (2002) · Nature · doi:10.1038/nature01026 · Cited by 656
Self-citationBiomaterial-based antimicrobial therapies for the treatment of bacterial infections
Kalelkar, P. P., Riddick, M., & García, A. J. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00362-4 · Cited by 548
Metadata
- Authors
- Nelson, D., Loomis, L., & Fischetti, V. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2001-03-20
- Volume
- 98
- Issue
- 7
- Pages
- 4107-4112
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2154066176
- Cited by
- 578
- References
- 17
- FWCI
- 18.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.